About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 676 record(s)
Req # A-2023-001158
All information included in the submission and review of Natural Product Number (NPN) 80059723 Berberine/Berberine 500 mg.Organization: Health Canada
February 2024
Req # A-2023-001203
Research/studies Health Canada uses to base the decisions on warning Canadians for pregabalin/Lyrica.Organization: Health Canada
February 2024
Req # A-2023-001225
All Microsoft (MS) teams and email messages conveying instructions to let staff off early on December 22, 2023. The range of dates for this is 2023-12-21 to 2023-12-22.Organization: Health Canada
February 2024
Req # A-2023-001249
All records mentioning “ribosomal frameshift”, “ribosomal frame shift”, “ribosomal frameshifting”, “ribosomal frame shifting”, “ribosomal frameshifts”, “ribosomal frame shifts”, in the context of Messenger Ribonucleic Acid (mRNA) vaccination since 2023-12-01.Organization: Health Canada
February 2024
Req # A-2023-001338
All emails referencing the Western Standard and/or Blacklock's Reporter and/or a Western Standard story headlined "Health Canada Says Drug Decriminalization Did Not Cause More Social Disorder" including but not limited to the following accounts: Anna.Maddison@hc-sc-gc.ca; Alexandra.Maheux@hc-sc.gc.ca; Christopher.Aoun@hc-sc.gc.ca; Media@hc-sc.gc.ca. In the period January 22 to January 25, 2024.Organization: Health Canada
February 2024
Req # A-2016-001311
The following documents: the Health Canada reviewer reports for RITUXAN SC related to review of Clinical, Clinical Pharmacology and Chemistry & Manufacturing information; and the Risk Management Plan (RMP) for RITUXAN SC.Organization: Health Canada
August 2023
Req # A-2018-000914
Information on adverse events related to medical devices. Hyaluronic acid or botulinum based products as of 2018-10-04. From 2015 - 2017.Organization: Health Canada
August 2023
Req # A-2018-001093
All information related to Natural Product Number (NPN) 80088599 provided, used and sent to and from Health Canada.Organization: Health Canada
August 2023
Req # A-2020-001730
A list of adverse reports that have resulted in deaths, regarding caffeinated energy drinks, taken from the consumption incident reports that have been received from Temporary Marketing Authorization Letter (TMAL) holders, in 2012, 2013 and 2016, as well as any other reports that resulted in death, within the incident reports that Health Canada has received since 2016.Organization: Health Canada
August 2023
Req # A-2021-000697
The briefing binder prepared for the head of the Canadian Drug Agency Transition Office. March 1, 2021 - April 30, 2021.Organization: Health Canada
August 2023